China’s Commerce Department said on Tuesday that the company’s “discriminatory measures against Chinese companies” undermined the legitimate rights and interests of Chinese companies, and that it would include major US biotech companies in its “unreliable entity list.” has been announced.
Illumina, the leading US genome sequencing company, was the first biotech company to be on the Beijing list. Over 60% of the world’s genetic sequencing data is generated by Illumina machines.
The company’s share price fell 5% after being blacklisted in Beijing.
02:52
China imposes tariffs on some US products due to 10% tax on Donald Trump in effect
China imposes tariffs on some US products due to 10% tax on Donald Trump in effect
The United States is a global leader in biotechnology. The Illumina list as an unreliable entity in China marks the turning point in the life sciences sector of the superpower’s technological warfare.
The development reflects both China’s biotechnology advances as it moves to bridge the gap with US scientists and businesses, and Beijing’s push to protect national security concerns and commercial interests. It’s there.
On September 9, the US House of Representatives passed a bill that attempted to limit business transactions between China’s Beijing Genomics Institute (BGI) and several other national security biotech companies, criticising Beijing. I urged. In October, Politico reported that the bill had progressed in Congress due to Illumina lobbying.
